AU7949394A - Reconstituted human antibody against human medulloblastomatous cell - Google Patents

Reconstituted human antibody against human medulloblastomatous cell

Info

Publication number
AU7949394A
AU7949394A AU79493/94A AU7949394A AU7949394A AU 7949394 A AU7949394 A AU 7949394A AU 79493/94 A AU79493/94 A AU 79493/94A AU 7949394 A AU7949394 A AU 7949394A AU 7949394 A AU7949394 A AU 7949394A
Authority
AU
Australia
Prior art keywords
medulloblastomatous
cell
antibody against
human
reconstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79493/94A
Other languages
English (en)
Inventor
Toshihiko Ohtomo
Koh Sato
Masayuki Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU7949394A publication Critical patent/AU7949394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU79493/94A 1993-11-19 1994-10-19 Reconstituted human antibody against human medulloblastomatous cell Abandoned AU7949394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29107893 1993-11-19
JP5-291078 1994-10-18
PCT/JP1994/001763 WO1995014041A1 (en) 1993-11-19 1994-10-19 Reconstituted human antibody against human medulloblastomatous cell

Publications (1)

Publication Number Publication Date
AU7949394A true AU7949394A (en) 1995-06-06

Family

ID=17764153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79493/94A Abandoned AU7949394A (en) 1993-11-19 1994-10-19 Reconstituted human antibody against human medulloblastomatous cell

Country Status (5)

Country Link
US (3) US6214973B1 (enExample)
EP (1) EP0729976A1 (enExample)
AU (1) AU7949394A (enExample)
TW (1) TW526206B (enExample)
WO (1) WO1995014041A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009651A1 (en) * 1996-09-03 1998-03-12 Chugai Seiyaku Kabushiki Kaisha ANTI-INTEGRIN α3 ANTIBODY COMPLEXES
EP2208784B1 (en) * 2001-06-22 2013-01-02 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors containing anti-glypican 3 antibody
CN1553952A (zh) * 2001-08-13 2004-12-08 ��ѧ�о��� 促进神经组织修复的材料和方法
CA2632822C (en) * 2005-12-12 2018-08-28 Ruth Greferath A beta 1-42 specific monoclonal antibodies with therapeutic properties
CL2007002070A1 (es) * 2006-07-14 2008-02-08 Ac Immune S A Genentech Inc Anticuerpo quimerico o humanizado, o fragmentos de ellos, que se adhieren especificamente a por lo menos un epitopo en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; su uso para tratar enfermedade
PE20131334A1 (es) * 2007-06-12 2013-11-13 Ac Immune Sa Anticuerpo igg1 humanizado
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
EP2205632B1 (en) * 2007-10-05 2016-11-16 Genentech, Inc. Use of anti-amyloid beta antibody in ocular diseases
ES2612788T3 (es) * 2007-10-05 2017-05-18 Genentech, Inc. Métodos y composiciones para el diagnóstico y tratamiento de la amiloidosis
HRP20140175T1 (hr) 2007-10-05 2014-04-11 Genentech, Inc. Upotreba protutijela protiv amiloida beta kod oäśnih bolesti
ES2426093T3 (es) 2008-01-10 2013-10-21 Shionogi & Co., Ltd. Anticuerpo dirigido contra PcrV
AU2011282536B2 (en) 2010-07-30 2015-12-24 Ac Immune S.A. Safe and functional humanized anti beta-amyloid antibody
MX2016009690A (es) 2014-02-03 2017-03-03 Nat Cancer Ct Anticuerpos monoclonal anti-factor de tejido.
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
WO2019230856A1 (ja) 2018-05-31 2019-12-05 塩野義製薬株式会社 Ｎａｖ１．７モノクローナル抗体
WO2020138489A1 (ja) 2018-12-27 2020-07-02 塩野義製薬株式会社 新規抗ｃｃｒ８抗体
US20230256092A1 (en) 2020-06-30 2023-08-17 Shionogi & Co., Ltd. Combined use of anti-ccr8 antibody and chemotherapeutic agent
EP4428239A4 (en) 2021-11-01 2025-10-29 Shionogi & Co NEW MONOCLONAL ANTIBODY NAV1.7
WO2023234406A1 (ja) 2022-06-03 2023-12-07 塩野義製薬株式会社 カンナビノイド１型受容体に結合する抗体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147500A (ja) * 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
WO1992019759A1 (fr) * 1991-04-25 1992-11-12 Chugai Seiyaku Kabushiki Kaisha Anticorps humains reconstitues diriges contre un recepteur de l'interleukine 6 humaine
AU669124B2 (en) * 1991-09-18 1996-05-30 Kyowa Hakko Kirin Co., Ltd. Process for producing humanized chimera antibody
DE4225853A1 (de) * 1992-08-05 1994-02-10 Behringwerke Ag Granulozytenbindende Antikörperfragmente, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
EP0729976A4 (enExample) 1996-10-16
US7563599B2 (en) 2009-07-21
US20030023045A1 (en) 2003-01-30
US20050249726A1 (en) 2005-11-10
WO1995014041A1 (en) 1995-05-26
TW526206B (en) 2003-04-01
EP0729976A1 (en) 1996-09-04
US6214973B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
AU6808194A (en) Reconstructed human antibody against human interleukin-6
AU4397297A (en) Antibody against human parathormone related peptides
AU7949394A (en) Reconstituted human antibody against human medulloblastomatous cell
AU6743894A (en) Truss
AU6923294A (en) Personal object carrying medical details
AU6665794A (en) Balanced modulator-transmitter
AU7612196A (en) Functional human hematopoietic cells
AU5744696A (en) In situ immunodetection of antigens
AU4818396A (en) Battery
AU7547094A (en) Combined chair
AU5866894A (en) Wheelchair
AU5277993A (en) Two-way high-leg recliner
AU6955494A (en) Red blood cell surrogate
AU6856896A (en) Reconstituted skin
AU4514093A (en) Recombinant antibody against human interleukin-1
AU6130196A (en) Cell treatment
AU7431294A (en) Chair
AU6700596A (en) Sandwich structure
AU5737494A (en) Human thrombospondin-4
AU4024293A (en) Mouthrinse
AU671934B2 (en) Chair
AU4594696A (en) Human stem cell antigen 2
AU646628B3 (en) Improvements in birdproofing
AU1289695A (en) Human stanniocalcin-alpha
AU6313694A (en) Colostrum preparation and storage